Needham Keeps 'Buy' on Scios

Analyst Mark Monane believes the drug maker's Natrecor heart medication will be approved by the FDA in July 2001

Needham reiterates buy on shares of Scios (SCIO ).

To continue reading this article you must be a Bloomberg Professional Service Subscriber.